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1. Introduction 
The classic triad of flank pain, palpable mass and hematuria exists in less than 20 percent of 
patients with renal cell carcinoma, and the tumor may become large in its origin before any 
local sign or symptom arises. Therefore, it is common to detect the tumor only after the 
metastasis develops. 
Renal cell carcinoma (RCC) may present with diverse range of clinical manifestations. Many 
cases of renal cell carcinoma are unsuspected initially. The same is true for tumor recurrence 
even several years after primary tumor resection. For instance, it is not uncommon for a 
thyroid nodule to be the presenting feature of metastatic RCC. Renal cell carcinoma may 
masquerade any other illness so it is named tumor of internal medicine. Here the clinical 
presentations of the tumor within different body organs are discussed. In the followings, 
the clinical spectrum is arranged by each system in the body. The symptoms and signs of 
tumor in the urinary system are discussed separately. The systemic manifestations of 
cancer-related treatment are not discussed here. 
2. Skin manifestations 
Dermatological manifestations of renal cell carcinoma are not common. However, there are 
reports of coetaneous metastases as the primary clue to the tumor diagnosis (Mueller et al., 
2004; Srinivasan, 2010). Skin nodules are more common. Scalp is the most prevalent site 
followed by chest and abdomen (Arrabal-Polo et al, 2009; Dorairajan et al., 1999).  
Small vessel vasculitis limited to skin has been noted in renal cell carcinoma. It causes 
papules, nodules and even skin ulceration. Maynard et al reported a case of an adult male 
with renal cell carcinoma that initially presented with leukocytoclastic vasculitis involving 
skin, joints and gastrointestinal tracts (Maynard, 2010). 
Palmar fibromatosis,acanthosis nigricans,hypertrichosis lanuginose,paraneoplastic 
erythroderma, bullous pemphigoid, and acquired  ichthyosis are rare coetaneous 
manifestations of internal malignancies that  are rarely reported in cases of renal cell 
carcinoma (Klein et al., 2009; Tebbe et al.,1991). 
Hence, it cannot be over emphasized that an occult cancer such as renal cell carcinoma 
needs to be considered in evaluation of an elderly patient presenting with systemic 
vasculitis or certain dermatologic disorders. 
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3. Musculoskeletal manifestations 
Renal cell carcinoma avidly involves the skeleton .After lung; the skeleton is the second 
most common site for metastases (Fottner et al., 2010). It ranks as the sixth solid tumor 
responsible for bone metastases that cause severe bone pain or debilitating skeletal 
complications such as pathologic fractures and spinal cord compression. Pelvis, ribs and 
vertebrae are the most prevalent sites for bone metastases. Patients with bone involvement 
portend a grave prognosis and most of them die within a year. Various therapeutic 
modalities such as chemo radiotherapy, surgery and bisphosphonates have been introduced 
with variable success (Lipton et al., 2004). 
A 54 year-old man presented with multiple pathologic fractures of thoracic vertebrae to my 
department. He was finally diagnosed to suffer from advanced renal cell carcinoma. He was 
a truck driver and noticed the severe back pain while fixing his truck. The fractures occurred 
when he was tightening the screws forcefully. Therefore, it seems prudent to look for a 
kidney cancer while confronting bone metastasis with unknown origin. 
Cancer and autoimmunity is a well-known inter-disciplinary entity .Tumor products behave 
as haptens triggering an overwhelming autoimmune response within the body. The 
autoimmune disorder may herald the presence of an occult cancer.  
Inflammatory myopathies, myositis and inclusion body myositis are reported as 
paraneoplastic syndromes associated with renal cell carcinoma. Klausner et al reported a 
case of 45- year -old man presented with polymyosistis that finally diagnosed to have renal 
cell carcinoma (Klausner et al, 2002). Similarly, Respicio et al reported a case of concurrent 
renal cell carcinoma, interstitial lung disease and polymyositis in a 58 year-old man 
(Respicio et al., 2007).It is not exactly known whether it is possible to predict the type of 
solid tumor at the time of inflammatory mysoitis by means of tumor biologic markers. 
Amoura et al  reported that  markers  as CA-125 and CA19-9 may predict developing the 
offending tumor in advance and need to be included in evaluation of patients with 
inflammatory myopathic syndromes(Amoura et al.,2005). 
A syndrome resembling to polymyalgia rheumatica (PMR) has been described as a 
paraneoplastic manifestation of solid tumors. The syndrome is not steroid responsive. Yet, it 
is not clear whether it will be improved after nephrectomy (Sidhom et al., 1993). Hence, it is 
reasonable to look for an occult solid tumor such as renal cell carcinoma in a patient with 
PMR refractory to steroids. Niccoli et al reported three patients presenting with PMR 
mimicking syndrome heralding renal cell carcinoma. They suggested that besides inefficacy 
of steroids, absence of morning stiffness and characteristic sonographic findings of shoulder 
are features of PMR mimicking syndrome associated with RCC (Niccoli et al., 2002). 
RS3PE (remitting symmetric sero negative synovitis with pitting edema) is a syndrome with 
symptoms similar to PMR; it occurs in patients older than 50 and may be associated with 
solid tumors or hematologic malignancies. It is mandatory to rule out an occult malignancy 
in the setting of RS3PE syndrome. Lung, breast, prostate and rarely kidney cancers have 
been reported as the underlying solid tumors in patients with this syndrome (Juncadella et 
al., 2003; Marto et al., 2010; Russel, 2005). 
Other rare rheumatic manifestations of renal cell carcinoma include metastatic monoarthritis 
and multi centric reticulo histiocytosis (MR). The latter is a syndrome presenting with 
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coetaneous nodules and severe destructive arthritis .It may be associated with an internal 
malignancy. Tan et al reported two cases of MR associated with urologic malignancies 
(Placed et al, 2010; Tan et al.2011). 
4. Nervous system manifestations 
Paraneoplastic neuropathy is a well-known autoimmune neuropathy associated with anti 
neuronal nuclear antibody. Roy et al (Roy et al., 2002) reported chronic sensory motor 
polyneuropathy in a 65-year-old man several months before the diagnosis of RCC. Allen et 
al also reported a case of acute demyelinating neuropathy in a case of papillary renal cell 
carcinoma that resolved following nephrectomy (Allen et al., 2011). Torvik et al reported 
three cases with necrotizing vasculitic involvement of peripheral nerves that were 
diagnosed to have renal cell carcinoma through postmortem follow up (Torvik & Berntzen, 
1968). 
Numb chin syndrome is numbness of lower lip, chine and gingiva of anterior lower teeth. It 
may be associated with a visceral malignancy such as lung, breast cancer or leukemia; 
however, it has been reported in renal cell carcinoma. Inferior alveolar/mental nerve is 
involved due to metastasis to mandible or nerve sheath infiltration by tumor (Divya et al., 
2010; Lata & Kumar, 2010). 
Opsoclonus is an ocular dyskinesia characterized by involuntary, repetitive, rapid conjugate 
saccades. It is most commonly seen in children. In an adult, it may herald an internal 
malignancy. Koukoulis A et al reported a case of paraneoplastic opsoclonus in a 64 year- old 
man. The patient was diagnosed to have papillary renal cell carcinoma 6 months after the 
diagnosis of opsoclonus (Koukoulis et al., 1998). 
Antinueronal nuclear antibody type 1 (classically known as anti –Hu) is detected in cancer 
associated autoimmune neurologic disorders (lucchinetti et al., 1998) .Patients develop 
various forms of neurologic disease including Lambert-Eaton myasthenic syndrome, 
encephalitis, cerebellar ataxia and so forth. For instance, Ammar et al reported a case of 64- 
year- old woman who presented with acute cerebellar ataxia as the initial manifestation of 
renal cell carcinoma (Ammar et al., 2008). There is also a report of bilateral diaphragmatic 
paralysis as a paraneoplastic neurologic disease secondary to RCC that ameliorated after 
nephrectomy (Rijnders & Decramer, 2000).Therefore, it is appropriate to investigate for an 
occult cancer when confronting an idiopathic bilateral diaphragmatic paralysis.  
Brain and spinal metastases are common in advanced stages of RCC. However, solitary 
brain metastasis and relevant clinical findings such as headache and focal neurologic deficit 
may be the presenting signs of the cancer (Candiano et al., 2010). Spinal metastases are 
usually extra dural but intradural involvement with resulting neurologic deficits, especially 
cauda equina syndrome were reported (Lin et al., 2011). Back pain and sciatica due to 
metastatic nerve root infiltration of lumbo sacral nerves have been reported in RCC patients 
(Shakeel et al., 2009).  Intramedullary spinal metastasis that are the rarest type of spinal 
involvement have also been reported as the presenting sign in RCC (Asadi et al., 2009; 
Donovan& Freeman, 2006; Gómez de la Riva et al., 2005; Schijns et al., 2000). Although 
uncommon, an occult cancer such as renal cell carcinoma needs to be considered in 
differential diagnosis of the above-mentioned syndromes.  
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5. Vascular system manifestations 
Renal vein and caval thromboses are among the well- known thrombotic events associated 
with renal cell carcinoma. Left-sided varicocele that does not decompress after taking the 
recumbent position is a well -known complication of the locally advanced RCC. It is due to 
tumor thrombus extending along the renal vein that blocks drainage of left spermatic vein 
into inferior vena cava (IVC).It is not just left spermatic vein that may become clogged .Right 
spermatic vein is at risk too. Shinsaka et al reported a case of right varicocele as a result of 
RCC thrombus in right spermatic vein without simultaneous caval thrombosis (Al-Taan et 
al., 2007;Shinsaka et al., 2006).Furthermore, prothrombotic state as a paraneoplastic feature 
of RCC may cause thrombosis in unusual sites such as subclavian veins(Hameed et al.,2011). 
Hence, it is worthwhile to consider RCC in evaluating patients with idiopathic venous 
thrombosis, especially in an unusual site. 
6. Hematologic manifestations 
Cytopenia, especially anemia is a common feature of the tumor. Polycythemia may also be 
seen, although less frequently (Mohammed Ilyas et al., 2008). Although, micro angiopathic 
hemolytic anemia, hemolytic uremic syndrome and disseminated intravascular 
coagulopathy may occur because of cancer chemotherapy in RCC, the tumor rarely presents 
with such a hematologic manifestation as thrombocytopenia .Yet, there are reports of 
metastatic RCC presenting with thrombocytopenia due to bone marrow carcinomatosis 
(Florcken et al., 2009). 
Disturbation in fibrinolysis system is a well –known feature of hematologic and non- 
hematologic tumors such as prostate cancer. Plasminogen is converted to plasmin; tissue 
plasminogen activator (t PA) or urokinase- type plasminogen activator (uPA) promotes the 
conversion. Some tumors express high level of tPA activity. This feature not only brings 
some sort of bleeding diathesis but also seems to be vital for tumor survival. In fact, the 
variable expression of fibrinolysis system components in a given cancer may affect the 
prognosis. For instance, patients with greater expression of u-PA on breast cancer cells have 
shorter survival and increased chance of relapse (Bell, 1996).In renal cell carcinoma, it has 
been demonstrated that expression of plasminogen inhibitor-1 is an independent poor 
prognostic factor as it promotes tumor angiogenesis and metastasis (Choi et al.,2011;Zubcaet 
al.,2010). Therefore, changes in hematologic parameters are not only paraneoplstic features 
of RCC but also of prognostic value.  
7. Pulmonary manifestations 
Lung metastases are common in natural history of RCC. Single or multiple variable –sized 
pulmonary nodules are usually detected in patients with advanced RCC. Regarding large 
reserve volume of lung, tumor burden may become so huge before any respiratory 
symptom such as dyspnea or cough develops. Besides this common mode of presentation, 
lymphangitic carcinomatosis may develop in setting of metastatic RCC. It is an interstitial 
lung disorder caused by lymphangitic spread of tumors such as breast, lung and rarely 
kidney cancer. It usually manifests with obstinate cough and progressive dyspnea. Wallach 
et al reported a case of 68 year -old man who presented with respiratory symptoms 20 
months after nephrectomy for stage III RCC. He had lymphangitic carcinomatosis. 
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According to their review of literature, there are less than 10 reports of such patients 
(Wallach et al., 2011). 
RCC metastases are not confined to lung parenchyma. There are reports of endobronchial 
metastases from RCC .Therefore hemoptysis or a pulmonary atelectasis may result from 
endobronchial spread of RCC.As the tumor is a hyper vascular one, it is mandatory to take 
precaution while planning local therapeutic modalities for symptomatic metastases (Mathai 
et al., 2007; Suyama et al., 2011).  
Malignant pleural effusion secondary to RCC is rare and usually seen with papillary and 
clear cell histological types. There are reports of special cases of malignant effusion 
secondary to RCC.As an example; Chetcuti K et al reported a case of massive spontaneous 
hemothorax in a 78 year- old man with a history of RCC. The culprit was a chest wall 
metastasis of RCC (Chetcuti et al., 2010; Teresa et al., 2011). 
Mediastinal lymph adenopathy and masses are seen in advanced stages of renal cell 
carcinoma or as presenting features of primary tumor or tumor recurrence. They are closely 
correlated with poor prognosis (Mattana et al., 1996; Winter et al., 2010). Niikura S et al 
reported a case of 62 year- old man presented with mediastinal lymph node enlargements 19 
years after nephrectomy for RCC (Niikura et al., 1999). 
Pulmonary infarction due to tumor emboli within pulmonary circulation is an unusual 
manifestation of renal cell carcinoma .The tumor emboli originates from thrombus 
extending along vena cava, right sided heart or proximal part of pulmonary artery (Shiono 
et al.,2001;Wieder et al.,2003). The disease presents with acute or sub acute cor pulmonale 
and cytological study of pulmonary artery sample helps diagnosis. 
Despite the grave prognosis associated with pulmonary involvement in patients with RCC, 
there is a report by Okubo Y et al who described a patient with an obstinate cough as the 
sole manifestation of non- metastatic RCC .Cough disappeared after nephrectomy and 
recurred with tumor relapse (Okubo et al., 2007). 
8. Cardiac manifestations 
Heart may be involved in different manners by a non-cardiac tumor. For example, certain 
chemotherapeutic drugs and radiotherapy have deleterious effects on heart. Opportunistic 
infection of cardiac chambers has been demonstrated because of immune suppression in 
cancer patients. The tumor may involve the pericardium and less frequently, 
myoendocardium.So malignant pericardial effusion is a common finding in advanced 
cancer patients (Kim et al., 2010). Although uncommon, there are reports of malignant 
pericardial effusion secondary to RCC (Zustovich et al., 2008). 
In RCC, vena cava thrombosis can extend beyond the hepatic veins into the right atrium 
(Kalkat et al., 2008) .However; there are reports of cardiac metastasis mimicking primary 
cardiac tumors without concurrent cava involvement (Aburto et al., 2009; Talukder et al., 
2010). For instance, Lee HJ et al demonstrated a case of 77- year- old man with 2- month 
history of RCC in whom cardiac metastasis caused left ventricular outflow tract obstruction 
(Lee et al., 2010). Miyamoto MI et al reported a case of metastatic renal carcinoma with a left 
atrial mass mimicking myxoma. They demonstrated that the mass was RCC metastasis 
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derived from pulmonary vein tumor extension. The pulmonary vein itself had been 
involved from adjacent mediastinal lymph nodes (Miyamoto& Picard, 2002). Cardiac 
metastasis in a patient with known history of primary cancer is not challenging to diagnosis. 
Yet it is not uncommon for a RCC to present initially with a cardiac mass (Crouch & 
Tak,2002).Therefore, it needs to be vigilant to the presence of an occult cancer when 
evaluating a cardiac mass even if it resembles a primary cardiac tumor and there is no extra 
cardio respratory symptom. 
Not only myopericardium is involved in RCC but also the endocardium may become 
diseased in RCC. Non-bacterial endocarditis is a well –known disease entity in various 
diseases such as HIV infection, connective tissue disorders and cancers. The exact 
mechanism is not yet defined but thrombophilic state associated with malignancy may be 
responsible. The most primary cancer site is pancreas (Johnson et al., 2010). In literature 
review, there is few report of RCC associated with non-bacterial thrombotic endocarditis. 
9. Gastrointestinal manifestations 
Gastrointestinal (GI) tract is involved by RCC in different ways. Stauffer’s syndrome 
constitutes reversible abnormalities in liver function tests including enzymes and pro 
thrombin time. It may present as hepatocellular or cholestatic liver disease. It is not due to 
liver metastasis and actually caused by humoral effects of inflammatory cytokines produced 
by the tumor. Therefore, the abnormalities disappear after tumor resection by nephrectomy 
(Kranidiotis et al., 2009). However, there are reports of renal cell carcinoma metastases to 
various organs of gastrointestinal tracts. 
Oral cavity metastases from RCC have been demonstrated. In fact, intraoral soft tissue 
metastases are not common. They usually originate from lung and breast cancers. Metastatic 
oral cavity lesions rarely present as the initial feature of an occult cancer. For instance, 
Maestre-Rodríguez O reported a case of 55- year-old man who underwent resection of a 
gingival tumor that finally diagnosed to be metastatic RCC (Will et al., 2008; Maestre-
Rodríguez et al., 2009). Esophageal metastasis producing local symptoms such as dysphagia 
is not surprising in a case of an advanced RCC (de los Monteros-Sanchez et al., 2004). 
Hematogenous spread of RCC to stomach is  seen, albeit with concomitant metastases in 
other organs, especially lungs (Pollheimer et al., 2008).Although uncommon, gastric 
metastasis and upper gastrointestinal bleeding may be the initial feature of RCC. Tiwari P et 
al reported a 58- year-old woman with a 2-week history of melena. The source of bleeding 
was a 3cm×5cm vascular polypoid antral mass .She was finally diagnosed to have metastatic 
RCC (Tiwari et al., 2010). 
 Intraluminal metastases from RCC may be the source of intestinal bleeding or less 
commonly intussusceptions. They may behave as the leading point for an intestinal 
obstruction and intussusceptions. Periampullary region,  duodenum and jejunum rank the 
most common sites .Yet, other sites as large bowel may be involved too (Eo et al., 2008; 
Loualidi et al., 2004; Nozawa et al., 2003; Papachristodoulou et al., 2004; Roviello et al., 2006; 
Sadler et al., 2007 Takeda et al., 2011). The above cases highlight the importance of 
considering RCC metastasis as a source of intestinal bleeding and/or obstruction, especially 
in patients with a known cancer history. 
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Liver is the organ that is frequently involved in advanced RCC (Staehler et al., 2010). Yet it is 
not the only solid organ within GI tract involved by RCC. Pancreatic metastasis may occur 
due to a close proximity to the left kidney. However, the pancreas may be involved as a nest 
for metastatic deposits even years after nephrectomy. Yokonishi T et al reported pancreatic 
metastasis in a 74 year -old man who had history of nephrectomy due to RCC 25 years 
before (Yokonishi et al., 2010). The physicians must be alert to pancreatic metastasis from 
renal cell carcinoma and differentiate it from primary tumors of the gland because the 
prognosis differs in each case. Ghavamian R et al reviewed 23 patients with metastatic RCC 
to the pancreas .They found that imaging features of metastatic RCC resembled the primary 
RCC and differed from pancreatic tumours such as adenocarcinoma. RCC is a hyper 
vascular tumour, hence the metastasis enhances in early phase of contrasted abdominal 
computed tomography. They also noticed that the mean interval for pancreatic metastases 
to develop after nephrectomy was 9.8 years (Ghavamian et al., 2000). 
Budd-Chiari syndrome defined by presence of abdominal pain, hepatomegaly and ascites 
has also been reported as a manifestation of renal cell carcinoma. The syndrome caused by 
tumor thrombus extending along vena cava. As a result, hepatic venous drainage system 
will be blocked .It may become fulminate if not treated on time (Moragnoni et al., 2010; Shih 
et al., 2009). 
Bowel ischemia may be seen in RCC not only as a complication of immunotherapy but also 
as a consequence of embolic infarcts from tumor thrombus in left heart (Low et 
al.,1989;Sparano etal.,1991). 
Sinistral portal hypertension refers to gastric variceal hemorrhage secondary to splenic vein 
thrombosis. It is most common in the setting of pancreatic pathologies such as pancreatitis, 
pseudocysts and cancer. There is no concurrent liver dysfunction (Singhal et al., 2006). Joya 
Seijo MD et al reported a case of sinistral portal hypertension and gastric bleeding as the 
initial manifestation of left sided RCC infiltrating the pancreas (Joya Seijo et al., 2004). RCC 
may rarely present with variceal bleeding. A 51- year- old man presented to our hospital 
with an episode of upper gastrointestinal bleeding twelve years after nephrectomy for a 
clear cell RCC. He was diagnosed to have downhill esophageal varices. They were formed 
by compressing effects of enlarged mediastinal lymph nodes upon the azygous vein 
.Pathologic review of the lymph nodes revealed recurrence of clear cell carcinoma. 
10. Endocrinologic system 
Like any other organ, endocrine system is not safe from RCC. Metastatic RCC may invade 
pituitary gland and mimics a nonfunctional pituitary adenoma (Kramer et al., 2010). 
Panhypopituitarism, suprasellar extension, headache, hemianopia, galactorrhea and 
diabetes insipidus are reported because of RCC metastasis to pituitary gland (Gopan et al., 
2007). Although uncommon, thyroid metastasis in  RCC has been demonstrated that can be 
of diagnostic challenge to be differentiated from primary thyroid tumors (Cimino-Mathews 
et al,2011).Adrenal, testicular and ovarian metastases have been reported in the course of 
disease even years after primary nephrectomy (Guney et al.,2010;Wu et al.,2010). Toquero L 
et al reported a case of 54- year old woman with a pelvic mass as an initial presentation of 
RCC. The mass was actually ovarian metastasis from RCC (Toquero et al., 2009).Ovarian 
metastases usually originate from stomach, colon, breast cancers and lymphoma. However, 
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RCC needs to be considered in differential diagnosis. The patients with this sort of 
metastasis in either testis or ovary usually seek medical care because of localized symptoms 
rather than a symptom relevant to hypogonadism.It is may be due to age of patients who 
are usually in 50s-70s. 
11. Paraneoplastic syndromes 
There are constellation of signs, symptoms and laboratory data abnormalities not related to 
tumor local effect or its metastases. Some of them such as Stauffer’s syndrome have been 
mentioned above. Most of them are cytokine mediated such as neoplastic fever (Alsirafy et 
al., 2011) .The remaining may be due to tumor products. Humoral hypercalcemia of 
malignancy is a paraneoplastic feature of various tumors. In RCC, it is multi factorial. 
Widespread bone metastases, parathormone-related peptide and increased production of 1, 
25 hydroxyvitamin D are responsible. Therefore, hypercalcaemia in patients with RCC may 
respond to administration of steroids (Shivnani et al., 2009).   
Glucose metabolism abnormalities have been demonstrated in association with RCC. The 
tumor can produce insulin like growth factor II resulting in hypoglycemia (Berman & 
Harland, 2001).On the other hand, hyper glycemia is reported as a paraneoplastic 
endocrinopathy in patients with RCC(Jobe et al.,1993).For instance, Yumura Y et al reported 
2 patients whose diabetes was controlled after nephrectomy for RCC (Yumura et al.,2007).  
Although hypertension is a complication of targeted therapy in RCC patients, it may 
develop as a paraneoplastic feature of kidney cancer not related to treatment 
(kirkali,2011).Some of the patients show increased blood level of renin and plasma renin 
activity as a possible cause of their increased blood pressure(Steffens et al.,1992). 
Gynecomastia attributable to human chorionic gonadotropin overproduction has been 
reported as another paraneoplastic endocrinopathy in RCC (Mohammed Ilyas et al., 2008).It 
has also been demonstrated that expression of beta subunit of human chorionic 
gonadotropin is associated with adverse prognosis in RCC (Hotakainen et al., 2002, 2006). 
Cancerous erythrocytosis is another rare para neoplastic disorder associated with RCC 
caused by over expression of erythropoietin and hypoxemia induced factor. However, only 
a small percentage of patients with over expression of erythropoietin develop 
paraneoplastic erythrocytosis (Wiesener et al., 2007).Although uncommon, paraneoplastic 
erythrocytosis of RCC may have grave sequels; Kruyt ND et al reported a case of 65- year -
old man who presented with neurologic deficits due to multiple cerebral infarctions as the 
initial presentation of RCC. His erythrocytosis and cognitive dysfunction relieved after 
nephrectomy for newly diagnosed RCC (Kruyt & Wessels, 2006). 
Although above-mentioned paraneoplastic syndromes are not common in RCC, they are of 
value for both diagnosis and estimating the prognosis of the primary tumor. 
12. Miscellaneous abnormalities 
RCC behaves unpredictably so it is common to confront its metastasis in unusual sites. The 
followings are some examples. It has been reported that renal cell carcinoma may initially 
present as an orbital mass, a mass within paranasal sinuses, gallbladder metastasis, 
cerebellopontine angle or superior vena cava syndrome due to supraclavicular lymph nodes 
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involvement (Cobo-Dolset al., 2006; Fang et al., 2010; Panarese et al., 2002; sakura et al., 2007; 
Mudiayanselage et al., 2008). 
13. Conclusion 
The classic triad of flank pain, hematuria and palpable abdominal mass occurs in a small 
fraction of patients with renal cell carcinoma, so it is wise to be aware of various clinical 
presentations of the disease. The above-mentioned clinical features are summarized in Table-1.  
 
Skin 
coetaneous metastases, Skin nodules, Small vessel vasculitis, Palmar 
fibromatosis,Acanthosis nigricans, Hypertrichosis lanuginose,Paraneoplastic 
erythroderma, Bullous pemphigoid,Acquired  ichthyosis 
Musculoskeletal system 
Bone metastases, Inflammatory myopathies, Myositis , Inclusion body myositis, 
Polymyalgia rheumatica- like syndrome, RS3PE (remitting symmetric sero negative 
synovitis with pitting edema), Metastatic monoarthritis and multi centric reticulo 
histiocytosis (MR) 
Nervous system 
Paraneoplastic neuropathy, Numb chin syndrome, Opsoclonus, Lambert-Eaton 
myasthenic syndrome, Encephalitis, Cerebellar ataxia, Bilateral diaphragmatic 
paralysis, Brain and spinal metastases 
Vascular system 
Renal vein and caval thromboses, Left sided varicocele, Prothrombotic state and 
thrombosis in unusual sites 
Hematologic system 
Cytopenia,Polycythemia, Micro angiopathic hemolytic anemia, Hemolytic uremic 
syndrome, Disseminated intravascular coagulopathy, Disturbation in fibrinolysis 
system 
Pulmonary system 
Single or multiple variable –sized pulmonary nodules, Lymphangitic carcinomatosis, 
Malignant pleural effusion, Mediastinal lymph adenopathy, Pulmonary infarction due 
to tumor emboli 
Heart 
Malignant pericardial effusion, Cardiac metastasis mimicking primary cardiac tumors, 
Non-bacterial endocarditis 
Gastrointestinal tract 
Stauffer’s syndrome, Oral cavity metastases, Esophageal metastasis, Gastric metastasis 
and upper gastrointestinal bleeding, Intraluminal metastases, Hepatic and pancreatic 
metastases, Budd-Chiari syndrome, Bowel ischemia due to tumor emboli, Sinistral 
portal hypertension, Gastric variceal bleeding 
Endocrinologic system 
Panhypopituitarism ,Metastasis to thyroid, adrenal, ovaries and testes 
Paraneoplastic syndromes 
Hypercalcaemia, Hypoglycemia, Hyperglycemia, Polycythemia, Gynecomastia, 
Hypertension 
Table 1. Clinical spectrum of patients with renal cell carcinoma 
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